HAEGARDA SAFETY AND TOLERABILITY

Adverse reactions occurring in >4% of patients while taking HAEGARDA

*Includes patients who were treated with 40 IU/kg and 60 IU/kg. Includes bruising, coldness, discharge, erythema, hematoma, hemorrhage, induration, edema, pain, pruritus, rash, injection-site reaction, scarring, swelling, urticaria, and warmth at the injection site. Includes hypersensitivity, pruritus, rash, and urticaria.

INJECTION-SITE REACTIONS WERE THE MOST COMMONLY REPORTED ADVERSE REACTIONS

  • 95% of injection-site reactions were of mild intensity
  • 83% of injection-site reactions resolved within 24 hours
  • No injection-site reactions were serious or led to discontinuation of therapy1

IN-HOME NURSE TRAINING THROUGH HAEGARDA CONNECTSM

HAEGARDA Connect offers your HAE patients in-home training to educate on safe practices and help get them comfortable with preparing and injecting HAEGARDA. This training is available at no cost to the patient. LEARN MORE

You are now leaving the current website.